首页> 外国专利> Term transplantation, and development of human hematopoietic cell lines of normal mammalian

Term transplantation, and development of human hematopoietic cell lines of normal mammalian

机译:正常哺乳动物的长期移植和人类造血细胞系的发育

摘要

A non-human chimeric mammal M4 having long-term stable xenogeneic hematopoietic cells, is obtained by doubly transplanting a mammal M1, the hematopoietic cells of which have been substantially suppressed or destroyed, with hematopoietic cells from at least two different sources, at least one of these sources being hematopoietic cells originating in a mammal M3 of a species other than that of mammal M1, preferably human, and at least a second of these sources being hematopoietic cells originating from a mammal M2, of a species other than that of M3, preferably of the same species as M1, having a genetically-determined hematopoietic deficiency. In particular, a chimeric mouse having long term stable human B and T cells was obtained by double engraftment of human bone marrow cells and of bone marrow cells derived from a mouse with severe combined immunodeficiency (SCID). IMAGE
机译:具有长期稳定的异种造血细胞的非人类嵌合哺乳动物M4,是通过将至少两个不同来源的造血细胞(至少一个)的造血细胞双重移植(已实质上抑制或破坏了该造血细胞)而获得的这些来源中,有至少一种来自哺乳动物M3以外的其他物种(最好是人类)的造血细胞,其中至少第二种是来自哺乳动物M2的不同于M3的其他物种的造血细胞,优选具有与M1相同的物种,具有遗传确定的造血功能缺陷。特别地,通过双重移植人骨髓细胞和源自具有严重联合免疫缺陷症(SCID)的小鼠的骨髓细胞,获得具有长期稳定的人B和T细胞的嵌合小鼠。 <图像>

著录项

  • 公开/公告号DK0438053T3

    专利类型

  • 公开/公告日1999-11-22

    原文格式PDF

  • 申请/专利权人 YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED;

    申请/专利号DK19910100047T

  • 发明设计人 REISNER YAIR;

    申请日1991-01-02

  • 分类号C12N15/00;C12P21/08;

  • 国家 DK

  • 入库时间 2022-08-22 01:56:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号